Mexico City [Mexico], April 7 (ANI): The Mexico Federal Commission for the Protection Against Sanitary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India's first domestically-produced COVID-19 vaccine, Covaxin.
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
New Delhi [India], April 1 (ANI): COVID-19 vaccination will be carried out at both public and private sector Vaccination Centres (CVCs) on all days of April, including gazetted holidays, the central government informed on Thursday.
New Delhi [India], March 30 (ANI): Dr Harsh Vardhan, Union Minister of Health and Family Welfare along with his wife Nutan Goel were administered the second dose of indigenously developed coronavirus vaccine 'Covaxin' at the Delhi Heart and Lung Institute on Tuesday.
Addis Ababa [Ethiopia], March 30 (ANI/Xinhua): Ethiopia registered 1,982 new COVID-19 cases in the past 24 hours, taking the nationwide tally to 202,545 as of Monday evening, according to the Health Ministry.
New Delhi [India], March 27 (ANI): Pune-based Serum Institute of India CEO Adar Poonawalla on Saturday informed that the trials for 'Covovax', a vaccine developed by Novavax, have begun in India, and added that he is hoping the vaccine launch will take place by September this year.
New Delhi [India], March 26 (ANI): Union Health Ministry informed that the cumulative number of COVID-19 vaccine doses administered in the country has crossed 5.69 crores on Friday.
New Delhi [India], March 25 (ANI): RS Sharma, Chairman, Empowered Group on COVID vaccination informed that now CoWIN does not schedule second dose vaccination appointment automatically.
New Delhi [India], March 22 (ANI): The cumulative number of COVID-19 vaccine doses administered in the country has crossed 4.72 crore with 19,65,635 doses being given on Monday, the Union Health Ministry said.